FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: melanoma

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

(OMEX, GNRC, MELA) - Stocks To Watch From DrStockPick.com!
Posted by drstockpick on September 26th, 2011

OMEX, Odyssey Marine Exploration Incorporated

Largest Known Silver Shipwreck Cargo to be Recovered Under UK Government Contract.

Read More
comment 0
Share
Tags:
OMEX, nyse:gnrc, Nasdaq:OMEX, MELA, Mela Sciences, NASDAQ:MELA, Odyssey Marine, melanoma, GNRC, skin cancer, Generac, shipwreck

KR, PVCT, - CRWESelect.com Stocks To Watch For Friday! Kroger, Provectus Pharmaceuticals
Posted by CRWESelect Stoc... on June 16th, 2011

The Kroger Co. (NYSE:KR)

Kroger is the nation's largest traditional grocery retailer, employs more than 338,000 associates who serve customers in 2,449 supermarkets and multi-department stores in 31 states under two dozen local banner names including Kroger, City Market, Dillons, Jay C, Food 4 Less, Fred Meyer, Fry's, King Soopers, QFC, Ralphs and Smith's.

Read More
comment 0
Share
Tags:
KR, NYSE:KR, Kroger, City Market, Dillons, Jay C, Food 4 Less, Smith's, Fred Meyer, Fry's, King Soopers, QFC, Ralph's, hepatocellular carcinoma, melanoma, OTC:PVCT, PH-10, Provectus Pharmaceuticals, PV-10, PVCT.OB, supermarket, Craig Dees, David Dillon, drug PH-10, drug PV-10, global Phase 3 trial, Provectus, The National Psoriasis Foundation

Biotech/Biodefense Stock News; Aethlon Medical (OTCBB: AEMD) Announces Multi-Target Exosome Assay Validation
Posted by investid on April 12th, 2011

SAN DIEGO - April 12, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) announced today that its wholly owned subsidiary Exosome Sciences, Inc.

Read More
comment 0
Share
Tags:
breast, SAN DIEGO - April 12, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) announced today that its wholly owned subsidiary Exosome Sciences, Inc. (ESI) has validated the ability of its Enzyme Linked Lectin Specific Assay (ELLSA) to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, lymphoma, and colorectal. In July 2010, ESI disclosed that it filed a patent relating to the development of an assay that would allow researchers to detect exosomes in blood and other fluids. In addition to research opportunities, Aethlon Medical plans to test ELLSA as a diagnostic to quantify the therapeutic capabilities of the Aethlon Hemopurifier? to remove immunosuppressive exosomes from the circulatory system of those afflicted with cancer. ESI is now preparing a market survey

ADVERTISE WITH US